CGON Cash-Secured Put Strategy

CGON (CG Oncology Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

CG Oncology, Inc., a late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States. The company’s product candidate is cretostimogene, an investigational oncolytic immunotherapy, which is in phase 2 clinical trials of cretostimogene in patients with high-risk NMIBC after BCG failure; a phase 3 clinical trials to evaluate the safety and efficacy of cretostimogene as monotherapy in the treatment of patients who have received adequate BCG therapy with high-risk BCG-unresponsive, CIS-containing NMIBC and BCG-unresponsive Ta, or T1 papillary tumors; phase 3 BOND-003 Cohort C trials as a single agent; phase 3 BOND-003 Cohort P as a single agent in patients with BCG-UR papillary-only NMIBC. It also develops cretostimogene monotherapy for intermediate-risk NMIBC following TURBT, which is in phase 3 PIVOT-006 clinical trials to assess the safety and efficacy of adjuvant cretostimogene; and cretostimogene monotherapy for high-risk NMIBC in phase 2 CORE-008 clinical trials to assess the safety and clinical outcomes of cretostimogene in treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC. The company was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. CG Oncology, Inc. was founded in 2010 and is headquartered in Irvine, California.

CGON (CG Oncology Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.62B, a beta of 0.23 versus the broader market, a 52-week range of 24.85-79.39, average daily share volume of 1.0M, a public-listing history dating back to 2024, approximately 142 full-time employees. These structural characteristics shape how CGON stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.23 indicates CGON has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a cash-secured put on CGON?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

CGON snapshot

As of August 14, 2026, spot at $75.34, ATM IV 89.40%, IV rank 35.59%, expected move 25.63%. The cash-secured put on CGON below is built from the end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.

Why this cash-secured put structure on CGON specifically: CGON IV at 89.40% is mid-range versus its 1-year history, so the credit collected on a CGON cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 25.63% (roughly $19.31 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CGON expiries trade a higher absolute premium for lower per-day decay. Position sizing on CGON should anchor to the underlying notional of $75.34 per share and to the trader's directional view on CGON stock.

CGON cash-secured put setup

The CGON cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CGON at $75.34 on that close, the first option leg uses a $71.57 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CGON chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CGON shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$71.57N/A

CGON cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

CGON cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on CGON. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on CGON

Cash-secured puts on CGON earn premium while a trader waits to acquire CGON stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CGON.

CGON thesis for this cash-secured put

The market-implied 1-standard-deviation range for CGON extends from approximately $56.03 on the downside to $94.65 on the upside. A CGON cash-secured put lets a trader earn premium while waiting to acquire CGON at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current CGON IV rank near 35.59% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on CGON should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CGON options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CGON-specific events.

CGON cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CGON positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CGON alongside the broader basket even when CGON-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on CGON carry tail risk when realized volatility exceeds the implied move; review historical CGON earnings reactions and macro stress periods before sizing. Always rebuild the position from current CGON chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on CGON?
A cash-secured put on CGON is the cash-secured put strategy applied to CGON (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With CGON stock at $75.34 on the most recent close, the strikes shown on this page are snapped to the nearest listed CGON chain strike and the premiums come straight from that session's bid/ask midpoint.
How are CGON cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the CGON cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 89.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CGON cash-secured put?
The breakeven for the CGON cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from the end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The CGON market-implied 1-standard-deviation expected move in the same options snapshot is approximately 25.63%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on CGON?
Cash-secured puts on CGON earn premium while a trader waits to acquire CGON stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning CGON.
How does current CGON implied volatility affect this cash-secured put?
CGON ATM IV is at 89.40% with IV rank near 35.59%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CGON analysis